Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Bioorg Med Chem. 2017 Nov 11;26(1):65–76. doi: 10.1016/j.bmc.2017.11.018

Figure 5.

Figure 5

Docking pose of compound 8 (cyan backbone) and compound 9 (salmon backbone) in the active site of AbFabI (PDB ID 4ZJU). (A) The 4-methoxy phenyl in compound 9 clashes with N156 if it maintains a binding pose similar to compound 8. As a result we observe a shift in the binding mode. (B) The shift in binding mode of compound 9 positions it in the unfavorable hydrophobic environment of L100 and I201 which likely explains the weak inhibitory activity of compound 9 in AbFabI.